Total Payments
$104,061
2024 Payments
$7,708
Companies
67
Transactions
958
Medicare Patients
3,293
Medicare Billing
$709,750
Payment Breakdown by Category
Other$52,750 (50.7%)
Food & Beverage$32,567 (31.3%)
Travel$11,725 (11.3%)
Consulting$7,002 (6.7%)
Education$16.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $52,750 | 23 | 50.7% |
| Food and Beverage | $32,567 | 891 | 31.3% |
| Travel and Lodging | $11,725 | 39 | 11.3% |
| Consulting Fee | $7,002 | 4 | 6.7% |
| Education | $16.24 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $37,711 | 61 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $24,339 | 28 | $0 (2018) |
| Abbott Laboratories | $15,414 | 151 | $0 (2024) |
| Nevro Corp. | $6,622 | 159 | $0 (2022) |
| Boston Scientific Corporation | $4,186 | 65 | $0 (2024) |
| Depomed, Inc. | $3,875 | 24 | $0 (2017) |
| BIOTRONIK NRO, Inc. | $1,913 | 37 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $934.69 | 48 | $0 (2024) |
| ABBVIE INC. | $732.95 | 40 | $0 (2024) |
| FORTE BIO-PHARMA LLC | $700.90 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,708 | 149 | Abbott Laboratories ($4,493) |
| 2023 | $14,517 | 175 | Abbott Laboratories ($9,803) |
| 2022 | $5,185 | 144 | Nevro Corp. ($1,032) |
| 2021 | $1,960 | 58 | Nevro Corp. ($809.59) |
| 2020 | $1,570 | 51 | Nevro Corp. ($555.24) |
| 2019 | $2,187 | 83 | Nevro Corp. ($1,349) |
| 2018 | $6,880 | 103 | AstraZeneca Pharmaceuticals LP ($4,586) |
| 2017 | $64,054 | 195 | Daiichi Sankyo Inc. ($37,667) |
All Payment Transactions
958 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $156.77 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $148.19 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $125.60 | General |
| Category: Neuromodulation | ||||||
| 12/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.04 | General |
| Category: Opioid Analgesic | ||||||
| 12/10/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $139.27 | General |
| Category: Neuromodulation | ||||||
| 12/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $172.03 | General |
| Category: Neuromodulation | ||||||
| 12/06/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $56.62 | General |
| Category: Not Applicable | ||||||
| 11/20/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: Opioid Analgesic | ||||||
| 11/14/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $138.26 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/12/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $21.29 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Neuromodulation | ||||||
| 10/31/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Not Applicable | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| Category: Opioid Analgesic | ||||||
| 10/07/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $12.61 | General |
| Category: Endocrinology | ||||||
| 10/05/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Not Applicable | ||||||
| 10/04/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $149.97 | General |
| Category: Neuromodulation | ||||||
| 10/04/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $118.55 | General |
| Category: Neuromodulation | ||||||
| 10/02/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: INSTRUMENTS | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PAIN | ||||||
| 09/27/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $115.93 | General |
| Category: Not Applicable | ||||||
| 09/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.86 | General |
| Category: Opioid Analgesic | ||||||
| 09/23/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $8.41 | General |
| Category: Endocrinology | ||||||
| 09/17/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $141.36 | General |
| Category: Neuromodulation | ||||||
| 09/14/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 795 | 1,733 | $1.3M | $110,803 |
| 2022 | 24 | 933 | 2,163 | $1.9M | $173,640 |
| 2021 | 22 | 746 | 1,559 | $1.5M | $219,797 |
| 2020 | 20 | 819 | 1,600 | $902,535 | $205,509 |
Total Patients
3,293
Total Services
7,055
Medicare Billing
$709,750
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 73 | 94 | $215,794 | $21,313 | 9.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 24 | 27 | $104,601 | $12,645 | 12.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 28 | 40 | $160,758 | $7,444 | 4.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 23 | 27 | $65,517 | $6,760 | 10.3% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 24 | 27 | $15,066 | $6,340 | 42.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $43,928 | $6,280 | 14.3% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 30 | 30 | $13,470 | $5,843 | 43.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 22 | 29 | $84,245 | $5,662 | 6.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 58 | $33,524 | $5,300 | 15.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 29 | 36 | $68,295 | $5,214 | 7.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 42 | 45 | $100,517 | $4,375 | 4.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 53 | 57 | $20,349 | $3,410 | 16.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 24 | 34 | $71,082 | $3,363 | 4.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 13 | 18 | $64,343 | $3,338 | 5.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 13 | 14 | $37,366 | $2,606 | 7.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 18 | 24 | $82,477 | $2,274 | 2.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 31 | $12,028 | $2,041 | 17.0% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 11 | 16 | $33,862 | $1,529 | 4.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 16 | 16 | $27,237 | $1,157 | 4.2% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 12 | 13 | $8,060 | $1,088 | 13.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 15 | 20 | $32,775 | $1,074 | 3.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 82 | 109 | $5,232 | $988.13 | 18.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 54 | 66 | $1,716 | $394.58 | 23.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 42 | 360 | $34,560 | $302.71 | 0.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 37 | 450 | $7,200 | $44.42 | 0.6% |
About Dr. Thomas Weber, DO
Dr. Thomas Weber, DO is a Pain Medicine healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568522399.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Weber, DO has received a total of $104,061 in payments from pharmaceutical and medical device companies, with $7,708 received in 2024. These payments were reported across 958 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($52,750).
As a Medicare-enrolled provider, Weber has provided services to 3,293 Medicare beneficiaries, totaling 7,055 services with total Medicare billing of $709,750. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Anesthesiology
- Location Raleigh, NC
- Active Since 12/11/2006
- Last Updated 04/08/2025
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1568522399
Products in Payments
- Movantik (Drug) $34,386
- MOVANTIK (Drug) $24,322
- PROCLAIM (Device) $11,330
- Senza Spinal Cord Stimulation System (Device) $4,781
- Morphabond ER (Drug) $3,307
- ETERNA (Device) $2,499
- Gralise (Drug) $2,201
- Omnia (Device) $1,841
- Prospera (Device) $1,774
- Nucynta (Drug) $1,766
- OCTRODE (Device) $1,432
- WaveWriter Alpha Prime 16 (Device) $777.63
- Nalocet (Drug) $630.65
- Nalu Neurostimulation System (Device) $607.23
- XTAMPZA (Drug) $511.33
- Excelsius Robotics System (Device) $478.08
- General - Pain Management (Device) $377.07
- QULIPTA (Drug) $375.31
- RELISTOR (Drug) $364.20
- Xeomin (Biological) $360.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Raleigh
Dr. Vijaysinha Mandhare, Md, MD
Pain Medicine — Payments: $18,794
Pain Medicine $18,794
Seung Kim, M.d, M.D
Pain Medicine — Payments: $13,955
Pain Medicine $13,955
Timothy Reis, D.o, D.O
Pain Medicine — Payments: $12,480
Pain Medicine $12,480
Dr. Robert Wadley, Md, MD
Pain Medicine — Payments: $6,433
Pain Medicine $6,433
Laurence Holman, Nurse Practitioner, NURSE PRACTITIONER
Pain Medicine — Payments: $6,405
Pain Medicine $6,405
Dr. Anuradha Rao-Patel, Md, MD
Pain Medicine — Payments: $309.77
Pain Medicine $309.77